By

Shubham Pharmachem Pvt. Ltd.
Tacrolimus is an immunosuppressant used with other medications to prevent the rejection of transplanted kidneys, hearts, liver, or lungs in organ transplants. It weakens the body’s immune system and helps the body accept the new organ as its own. ⁹ Administration The following guidelines must be observed during the administration of Tacrolimus: The medicine should...
Continue Reading
Dapagliflozin treats type 2 diabetes mellitus alone or in conjunction with other medications. It aids in blood sugar regulation, lowers the risk of severe consequences from diabetes, and shields against heart disease. By preventing glucose absorption in the proximal tubule of the nephron and inducing glycosuria, it helps individuals control their blood sugar levels when...
Continue Reading
Inhibiting clot formation with Rivaroxaban
Rivaroxaban is an oral anticoagulant which helps prevent the formation of harmful blood clots in the legs, lungs, brain, and heart. It makes blood flow through the veins more efficiently, which means that blood will be less likely to make a dangerous blood clot. Blood clots may occur in patients with: an irregular heartbeat (atrial...
Continue Reading
Entrepreneurship in the pharmaceutical industry
Entrepreneurship is crucial to instil innovation in our developing and evolving society. The pharmaceutical industry offers several entrepreneurial opportunities. Between 2005 to 2022, its revenue has more than doubled, registering unprecedented growth. The pandemic and its impact The coronavirus pandemic has improved several pharmaceutical businesses’ reputations while also increasing their earnings. The future development potential...
Continue Reading
Ticagrelor - Keeping blood clots at bay
Ticagrelor belongs to a group of medicines called antiplatelet agents. It prevents platelets (a type of blood cell) from forming blood clots that can cause heart attacks and strokes. It is also used to inhibit blood clots from forming in people who have had coronary stents. Thus, it lowers your risk of heart attacks, stroke,...
Continue Reading
Sitagliptin Phosphate Monohydrate - Role in treating type 2 diabetes
Sitagliptin is a medicine used to treat type 2 diabetes mellitus. It is used together with a healthy diet and regular exercise to control blood sugar levels. It also helps to prevent severe complications of diabetes, like kidney damage and blindness. Mechanism of action It is used with immediate or extended-release metformin, given separately or...
Continue Reading
POST-COVID-19 TRENDS IN THE PHARMACEUTICAL INDUSTRY
The Covid-19 pandemic has changed the pharmaceutical industry by providing a new impetus to enhance healthcare and wellness. It has pushed healthcare services to improve telemedicine, digital therapeutics, and decentralised clinical trials. It has also altered conventional marketing methods by increasing the need for online marketing. Post Covid-19, new trends have emerged within the pharmaceutical...
Continue Reading
Midazolam is a benzodiazepine used to help relax a patient before minor surgery, dental work, or other medical procedures. It causes drowsiness, relieves anxiety and prevents any event memory. Sometimes, it may be a short-term treatment of insomnia and emergency treatment of seizures. However, it must be used safely and under medical supervision since it...
Continue Reading
Pectin – Improves blood sugar and fat levels
Pectin is a well-known fibre found in fruits and vegetables. It occurs in the cell walls of the vegetables and fruits to give them structure. Upon integration with acid and sugar, jellies and jams form a semisolid consistency when it is cooled. Some fruits contain high pectin levels, such as quince and apples, seeds, rinds,...
Continue Reading
The PLI is an exciting opportunity for the pharma industry to be a part of the 'Atma Nirbhar Bharat' vision for the Government of India.
The Government of India has announced a new scheme, the Production Linked Incentive Scheme (PLI), to encourage the domestic manufacturing of pharmaceuticals. The PLI schemes play a vital role in the government’s push for achieving an Atma Nirbhar Bharat. It offers 15,000 crore INR in incentives for identified pharma products. Objective of the PLI scheme...
Continue Reading
1 2 3 11